Product image of Бериате (Human Coagulation Factor Viii) supplied by GNH India

Бериате

Active Ingredient:
Human Coagulation Factor Viii
Origin:
EU

Бериате (Human Coagulation Factor Viii)

Бериате is a human coagulation factor VIII product used to control and prevent bleeding in patients with hemophilia A. This intravenous therapy supports blood clotting by replacing missing or deficient factor VIII. Suitable for routine prophylaxis and on-demand treatment of bleeding episodes.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Human coagulation factor VIII, like Бериате, is primarily used to manage hemophilia A, a genetic disorder causing insufficient clotting factor VIII. It helps prevent and treat bleeding episodes by restoring normal clotting function. This therapy is also used for perioperative management to reduce bleeding risk during surgical procedures in affected patients.

Side Effects

  • When administered, Бериате works by temporarily increasing factor VIII levels in the bloodstream, supporting the natural clotting process. Users may notice reduced frequency or severity of bleeding episodes after consistent use. The product is designed to integrate into the body’s clotting mechanism without introducing foreign substances.

Precautions & Warnings

  • Store Бериате in a cool, dry place away from direct sunlight. Always check the product’s expiration date before use and ensure proper reconstitution as directed. Keep out of reach of children and pets. Discard any unused solution after use according to local guidelines for medical waste disposal.

Avoid Interactions

  • No known direct drug interactions have been established for Бериате. However, patients should inform their healthcare provider about all medications, supplements, or herbal products they are using. Caution is advised when combining with other therapies that may affect blood clotting or coagulation pathways.

Frequently Asked Questions

Бериате is used to treat and prevent bleeding in patients with hemophilia A by replacing missing factor VIII.

Бериате is given as an intravenous injection, typically under medical supervision.

Availability varies by region; consult a licensed pharmacy or healthcare provider for purchase options.

Possible side effects may include headache, nausea, or allergic reactions; consult a doctor if symptoms occur.

Бериaте is specifically for patients with hemophilia A due to factor VIII deficiency.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT